PT92949A - Processo para a preparacao de composicoes farmaceuticas contendo derivados da cisteina para o tratamento de doencas associadas com infeccoes provocadas por virus da imunodeficiencia humano - Google Patents

Processo para a preparacao de composicoes farmaceuticas contendo derivados da cisteina para o tratamento de doencas associadas com infeccoes provocadas por virus da imunodeficiencia humano

Info

Publication number
PT92949A
PT92949A PT92949A PT9294990A PT92949A PT 92949 A PT92949 A PT 92949A PT 92949 A PT92949 A PT 92949A PT 9294990 A PT9294990 A PT 9294990A PT 92949 A PT92949 A PT 92949A
Authority
PT
Portugal
Prior art keywords
preparation
treatment
pharmaceutical compositions
compositions containing
human immunodeficiency
Prior art date
Application number
PT92949A
Other languages
English (en)
Other versions
PT92949B (pt
Inventor
Wulf Droge
Leonard A Herzenberg
Leonore A Herzenberg
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of PT92949A publication Critical patent/PT92949A/pt
Publication of PT92949B publication Critical patent/PT92949B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
PT92949A 1989-01-26 1990-01-24 Processo para a preparacao de composicoes farmaceuticas contendo derivados da cisteina para o tratamento de doencas associadas com infeccoes provocadas por virus da imunodeficiencia humano PT92949B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30239689A 1989-01-26 1989-01-26

Publications (2)

Publication Number Publication Date
PT92949A true PT92949A (pt) 1990-07-31
PT92949B PT92949B (pt) 1995-12-29

Family

ID=23167578

Family Applications (1)

Application Number Title Priority Date Filing Date
PT92949A PT92949B (pt) 1989-01-26 1990-01-24 Processo para a preparacao de composicoes farmaceuticas contendo derivados da cisteina para o tratamento de doencas associadas com infeccoes provocadas por virus da imunodeficiencia humano

Country Status (25)

Country Link
US (1) US5607974A (pt)
JP (1) JPH04504570A (pt)
KR (1) KR940002820B1 (pt)
AU (1) AU639686B2 (pt)
BE (1) BE1004168A3 (pt)
CA (3) CA1339256C (pt)
CH (1) CH683499A5 (pt)
DE (1) DE4090165T (pt)
DK (1) DK139191A (pt)
FR (1) FR2643557B1 (pt)
GB (1) GB2243296B (pt)
GR (1) GR900100048A (pt)
IE (1) IE62795B1 (pt)
IL (1) IL93162A (pt)
IT (1) IT1237999B (pt)
LU (1) LU87977A1 (pt)
MA (1) MA21739A1 (pt)
MX (1) MX173567B (pt)
NL (1) NL9020094A (pt)
OA (1) OA09503A (pt)
PT (1) PT92949B (pt)
SE (1) SE9101815L (pt)
TN (1) TNSN90009A1 (pt)
WO (1) WO1990008540A1 (pt)
ZA (1) ZA90245B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554655A (en) * 1991-09-30 1996-09-10 Jess G. Thoene Method of treating HIV infection
PT100914A (pt) * 1991-09-30 1993-10-29 Jess G Thoene Uso de compostos capazes de sofrer uma permuta mista com dissulfureto, com uma ligacao dissulfureto, no tratamento de infeccao por hiv
EP0600462A1 (en) * 1992-12-01 1994-06-08 Nippon Flour Mills Co., Ltd. Reverse transcriptase inhibitors and antiviral agents
AU6060694A (en) * 1993-05-10 1994-11-17 Transcend Therapeutics, Inc Method for treating acquired immune deficiency syndrome
DE4325547C2 (de) * 1993-07-29 1997-11-27 Max Planck Gesellschaft Verwendung von Thiolverbindungen zur Therapie von Hepatitis-_Viren-induzierten Erkrankungen
WO1995010268A1 (en) * 1993-10-15 1995-04-20 Thoene Jess G Prevention of hiv infection
US5725870A (en) * 1993-10-15 1998-03-10 Thoene; Jess G. Methods, composites and articles for contraception
US5786152A (en) * 1996-04-26 1998-07-28 Amgen Inc. Methods of inhibiting syp binding to a CTLA-4 receptor
HUP9602024A3 (en) * 1996-07-25 1999-05-28 Toth Sandor Pharmaceutical composition containing aminoacid for external use
TW517089B (en) 1996-09-03 2003-01-11 Res Dev Foundation Assessment of intracellular cysteine and glutathione concentrations
US6013632A (en) * 1997-01-13 2000-01-11 Emory University Compounds and their combinations for the treatment of influenza infection
US6331610B1 (en) * 1997-04-25 2001-12-18 Metatron, Inc. Method for treating AIDS and HIV infection using select peptides from the beta subunit of human chorionic gonadotropin
US6020205A (en) * 1998-04-10 2000-02-01 Immunosciences Lab, Inc. Determination of intracellular antioxidant levels
US6251868B1 (en) * 1998-04-30 2001-06-26 Teijin Limited Method for treating a human immunodeficiency virus infection
US6566401B2 (en) * 2001-03-30 2003-05-20 The Board Of Trustees Of The Leland Stanford Junior University N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
US6355682B1 (en) * 2001-05-11 2002-03-12 Assa Weinberg Treatment of acute renal failure by administration of N-acetylcysteine
ITMI20011863A1 (it) * 2001-09-05 2003-03-05 Zambon Spa Associazione di farmaci contro il virus dell'influenza
US20050070607A1 (en) * 2003-08-19 2005-03-31 James Andrus N-acetylcysteine compositions and methods for the treatment and prevention of cysteine/glutathione deficiency in diseases and conditions
US7883703B2 (en) 2003-11-14 2011-02-08 The Brigham And Women's Hospital, Inc. Methods of modulating immunity
ITMI20032528A1 (it) * 2003-12-19 2005-06-20 Francesco Santangelo Uso di cistina o di cisteina per la prevenzione e il
US20070053970A1 (en) * 2005-05-25 2007-03-08 Guilford F T Liposomal formulation for oral administration of glutathione (reduced) and/or methylcobalamine for diseases related to glutathione deficiency and deficiency of the methionine remethylation pathway

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4148885A (en) * 1973-09-25 1979-04-10 Institut Merieux Immunostimulant medicine
FR2408387A2 (fr) * 1975-06-30 1979-06-08 Oreal Compositions a base de dispersions aqueuses de spherules lipidiques
US4440788A (en) * 1980-05-13 1984-04-03 Mitsubishi Chemical Industries, Limited Cysteine derivatives
US4434158A (en) * 1981-02-11 1984-02-28 Cornell Research Foundation Cysteine delivery system
US4335210A (en) * 1981-02-11 1982-06-15 Cornell Research Foundation Method of producing L-cysteine
US4665082A (en) * 1981-02-11 1987-05-12 Cornell Research Foundation Cysteine delivery system
US4647571A (en) * 1981-02-11 1987-03-03 Cornell Research Foundation Cysteine delivery composition
US4438124A (en) * 1981-02-11 1984-03-20 Cornell Research Foundation, Inc. Cysteine delivery system
US4879370A (en) * 1983-12-02 1989-11-07 Cornell Research Foundation, Inc. Glutathione delivery system
US4767785A (en) * 1984-01-18 1988-08-30 Michael Georgieff Hypocaloric preparation and intravenous method for hypocaloric treatment of patients
US4744989A (en) * 1984-02-08 1988-05-17 E. R. Squibb & Sons, Inc. Method of preparing liposomes and products produced thereby
EP0158487B1 (en) * 1984-04-09 1991-08-28 Takeda Chemical Industries, Ltd. Stable composition of interleukin-2
US4789633A (en) * 1984-04-19 1988-12-06 University Of Tennessee Research Corporation Fused liposome and acid induced method for liposome fusion
US4710489A (en) * 1985-04-22 1987-12-01 Cornell Research Foundation, Inc. Glutathione delivery system
US4758551A (en) * 1986-07-08 1988-07-19 Cornell Research Foundation, Inc. Methods for combatting renal toxicity due to metals or nephrotoxic drugs and for selectively modulating in vivo formation of leukotriene types
DE3707127C2 (de) * 1987-03-05 1996-06-20 Zambon Spa Verwendung von Methionin zur Behandlung von Immun-Schwächeerkrankungen bei Virusinfektionen und/oder bei Tumorerkrankungen
DE3812008A1 (de) * 1987-04-10 1988-10-20 Pfrimmer Pharma Verwendung von l-(-)-thiazolidin-4-carbonsaeure als cysteinquelle bei gestoerter cysteinsynthese
US4895716A (en) * 1987-06-09 1990-01-23 Biogen, Inc. Stabilized formulations of gamma interferons
DE3906671A1 (de) * 1989-03-02 1990-09-06 Wulf Prof Dr Droege Orales, magenvertraegliches n-acetylcysteinpraeparat hoher dosierung

Also Published As

Publication number Publication date
GR900100048A (el) 1991-06-07
IE62795B1 (en) 1995-03-08
DK139191D0 (da) 1991-07-25
DE4090165T (pt) 1991-11-21
MX173567B (es) 1994-03-16
SE9101815D0 (sv) 1991-06-13
AU639686B2 (en) 1993-08-05
IT9019141A1 (it) 1991-07-24
GB2243296A (en) 1991-10-30
IL93162A0 (en) 1990-11-05
MA21739A1 (fr) 1990-10-01
FR2643557A1 (fr) 1990-08-31
JPH04504570A (ja) 1992-08-13
IT9019141A0 (it) 1990-01-24
IT1237999B (it) 1993-06-21
KR940002820B1 (ko) 1994-04-04
IL93162A (en) 1995-03-15
GB2243296B (en) 1992-10-21
BE1004168A3 (fr) 1992-10-06
NL9020094A (nl) 1991-10-01
GB9112420D0 (en) 1991-07-31
PT92949B (pt) 1995-12-29
SE9101815L (sv) 1991-06-13
WO1990008540A1 (en) 1990-08-09
OA09503A (en) 1992-11-15
LU87977A1 (fr) 1992-03-11
KR910700045A (ko) 1991-03-13
AU4969490A (en) 1990-08-24
CA2045180A1 (en) 1990-07-27
FR2643557B1 (fr) 1995-02-03
CH683499A5 (it) 1994-03-31
CA1339256C (en) 1997-08-12
TNSN90009A1 (fr) 1991-03-05
CA1339070C (en) 1997-07-29
US5607974A (en) 1997-03-04
DK139191A (da) 1991-07-25
IE900073L (en) 1990-07-26
ZA90245B (en) 1990-10-31

Similar Documents

Publication Publication Date Title
PT92949A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados da cisteina para o tratamento de doencas associadas com infeccoes provocadas por virus da imunodeficiencia humano
PT88930A (pt) Processo para a preparacao de novos analogos de nucleosidos e de composicoes farmaceuticas que os contem
PT98944A (pt) Processo de preparacao de anticorpos alterados e de composicoes farmaceuticas para a prevencao e tratamento de infeccoes
MY107843A (en) Anti-viral compounds.
BR0017030B8 (pt) derivados de tiazolilamida, processo para sua preparação, composição farmacêutica que os compreende e uso dos mesmos
PT91731A (pt) Processo para a preparacao de composicoes farmaceuticas contendo ciclosporinas
RU94002475A (ru) Фармацевтическая композиция и ее применение для лечения вирусных инфекций
ITMI931522A1 (it) Composizione farmaceutiche per il trattamento dell'infezione da virus dell'epatite b (hbv)
ES2011210A4 (es) Derivados de gem-difosfonato subtituido por fenol, proceso para su preparacion y composiciones farmaceuticas conteniendolos
PT87190A (pt) Processo para a preparacao de composicoes farmaceuticas para a reducao dos efeitos indesejaveis das beta-lactaminas
BR9105239A (pt) Heparosanos-n,o-sulfatados,composicao contendo os mesmos e processo de preparacao da mesma,composicao farmaceutica e cepa de escherichia coil
BR9406509A (pt) Compostos processo sua preparação uso dos mesmos composições farmaceuticas e processo para profilaxia e para tratamento terapeutico de malária e doenças causadas por leishmania toxoplasma gondil pneumocy
PT92120A (pt) Processo para a preparacao de composicoes oftalmologicas contendo ciclosporina
PT87957A (pt) Processo para a preparacao de uma composicao farmaceutica contendo um analogo da somatostatina
BR9912142A (pt) 6-benzil-4-oxipirimidinas substituìdas, processopara sua preparação e composições contendo-as
BR9306207A (pt) Composiçao farmacéutica e processo para o tratamento de infecçao ou doença causada pelo vírus da hepatite b processo para a preparaçao da composiçao e uso de fiau ou de uma pró-droga ou metabolito do mesmo
ES2072332T3 (es) Derivados de la dibenzo(1,5)dioxocin-5-ona, su uso en medicamentos y procedimiento para su fabricacion.
BR9407862A (pt) Composto de flavina flavina derivado de flavina ou uma mistura que compreende duas ou mais destas composiçao farmacêutica e processo para o tratamento por profilaxia ou terapia de doença causada por infecçao virótica
PT87004A (pt) Process for the preparation of compositions for the treatment of viral infections and composites 3'-azide-2',3'-didesoxy-in osine and 3'-fluoro-2',3'-didesoxyguanosine
PT92922A (pt) Processo para a preparacao de composicoes farmaceuticas liquidas contendo derivados de piperidinoalcanol
PT91745A (pt) Processo para a preparacao de uma composicao contendo acidos da bilis uteis para o tratamento de infeccoes virais
PT82765A (pt) Processo para a preparacao de factor supressor activante e de composicoes farmaceuticas para o tratamento de doencas auto-imines
PT90169A (pt) Processo para a preparacao de composicoes farmaceuticas contendo timopentina para o tratamento de pacientes sofrendo de viremias provocadas por hiv
PT90329A (pt) Processo para a preparacao de peptidos protectores derivados do virus-1 da imunodeficiencia humana, gp 160
PT95810A (pt) Processo para a preparacao de composicoes farmaceuticas injectaveis contendo um alcaloide de bis-indol como ingrediente activo

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19950905

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19970331